Disclosure UK

Disclosure UK

The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines. 

It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.

This information will be published on the database - Disclosure​ UK. 

Disclosure UK database


Disclosure UK is part of a Europe-wide initiative​ to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.

Explore the data further

As well as searching Disclosure UK, you can also review each pharmaceutical company’s methodological note or download the full dataset by year.

2025 timeline for 2024 disclosure data

Submission deadline for companies abiding by the ABPI Code of Practice: 14:00 GMT Friday 28 March 2025

Publication of 2024 data on Disclosure UK: Friday 27 June 2025

Deadline 871X581
Pfizer Doctor

European Disclosure Gateway

To improve access to European data, the pharmaceutical industry has voluntarily created this single point of access to help any interested stakeholder navigate the publicly available data across all EFPIA Members countries whether hosted on individual company websites or centralised on national platforms.


Disclosure UK publications